URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Kishan Pandya

Concepts (262)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Combined Chemotherapy Protocols
19
1982
409
2.550
Why?
Breast Neoplasms
20
1980
660
2.090
Why?
Lung Neoplasms
12
1986
422
1.630
Why?
Hot Flashes
4
2000
28
1.450
Why?
Carcinoma, Non-Small-Cell Lung
7
2000
66
1.330
Why?
Cyclohexanecarboxylic Acids
3
2004
47
1.080
Why?
Amines
3
2004
64
1.080
Why?
gamma-Aminobutyric Acid
3
2004
90
1.050
Why?
Tamoxifen
7
1994
80
0.980
Why?
Neoplasms
9
1988
701
0.860
Why?
Taxoids
2
2009
14
0.840
Why?
Neoplasm Metastasis
15
1980
219
0.820
Why?
Colonic Neoplasms
4
1986
122
0.780
Why?
Antineoplastic Agents
8
1982
598
0.780
Why?
Pain
4
1993
363
0.710
Why?
Analgesics
3
1993
108
0.670
Why?
Middle Aged
42
1980
9461
0.670
Why?
Carboplatin
1
2009
29
0.660
Why?
Fluorouracil
10
1986
77
0.650
Why?
Imidazoles
1
2009
63
0.640
Why?
Diphosphonates
1
2009
40
0.640
Why?
Aged
34
1982
6986
0.600
Why?
Carcinoma, Small Cell
1
2007
33
0.590
Why?
Female
47
1980
19061
0.590
Why?
Sirolimus
1
2007
31
0.590
Why?
Neoplasm Recurrence, Local
8
1980
272
0.580
Why?
Protein Kinase Inhibitors
1
2007
91
0.550
Why?
Radiation-Sensitizing Agents
4
2001
72
0.520
Why?
Menopause
2
1993
40
0.510
Why?
Aged, 80 and over
13
1993
2423
0.510
Why?
Paclitaxel
4
2001
56
0.490
Why?
Humans
57
1980
35000
0.490
Why?
Cisplatin
8
1986
93
0.490
Why?
Antineoplastic Agents, Phytogenic
4
2000
38
0.470
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.460
Why?
Adult
32
1982
10906
0.450
Why?
Acetates
1
2004
64
0.450
Why?
Treatment Outcome
12
1993
2487
0.440
Why?
Drug Administration Schedule
7
1998
362
0.370
Why?
Endometrial Neoplasms
1
2001
36
0.360
Why?
Male
28
1980
18870
0.360
Why?
Clonidine
1
2000
33
0.350
Why?
Neoplasm Staging
4
2007
326
0.350
Why?
Adrenergic alpha-Agonists
1
2000
37
0.350
Why?
Postmenopause
1
2000
42
0.350
Why?
Antineoplastic Agents, Hormonal
1
2000
44
0.340
Why?
Drug Prescriptions
2
1993
44
0.340
Why?
Rectal Neoplasms
3
1986
82
0.340
Why?
Etoposide
4
1995
73
0.340
Why?
Remission Induction
8
1989
155
0.320
Why?
Appetite Stimulants
1
1998
1
0.310
Why?
Megestrol Acetate
1
1998
1
0.310
Why?
Survival Rate
6
1998
584
0.310
Why?
Carcinoma, Renal Cell
1
1998
55
0.290
Why?
Minority Groups
1
1997
52
0.290
Why?
Interferon-alpha
1
1998
84
0.290
Why?
Kidney Neoplasms
1
1998
101
0.290
Why?
Follow-Up Studies
8
1992
1757
0.280
Why?
Ambulatory Care
2
1994
140
0.280
Why?
Pilot Projects
7
1985
426
0.270
Why?
Chemotherapy, Adjuvant
2
1994
85
0.260
Why?
Amenorrhea
1
1994
18
0.240
Why?
Double-Blind Method
4
2000
985
0.240
Why?
Nausea
3
1980
153
0.220
Why?
Cyclophosphamide
5
1982
169
0.220
Why?
Combined Modality Therapy
5
1985
459
0.210
Why?
Administration, Oral
3
2000
302
0.210
Why?
Vomiting
2
1992
114
0.210
Why?
Palliative Care
2
1989
151
0.210
Why?
Doxorubicin
5
1995
102
0.210
Why?
Proportional Hazards Models
3
2000
398
0.210
Why?
Research Design
2
1988
326
0.200
Why?
Vincristine
4
1982
57
0.190
Why?
Survival Analysis
7
1993
575
0.190
Why?
Pain Measurement
2
1994
241
0.190
Why?
Disease-Free Survival
3
1994
191
0.190
Why?
Physician's Practice Patterns
1
1993
223
0.180
Why?
Canada
2
1994
75
0.180
Why?
Vitis
1
2010
3
0.180
Why?
Adenocarcinoma
4
1995
431
0.180
Why?
Questionnaires
4
1993
942
0.170
Why?
Hospitals, Community
1
1990
67
0.170
Why?
Beverages
1
2010
30
0.170
Why?
Mitomycin
4
1986
18
0.170
Why?
Time Factors
6
1980
3047
0.160
Why?
Spiro Compounds
1
1988
4
0.160
Why?
Fibroblast Growth Factor 7
1
2008
11
0.160
Why?
Pneumonectomy
1
2008
13
0.150
Why?
Antidepressive Agents
1
2009
88
0.150
Why?
Liver Neoplasms
4
1980
149
0.150
Why?
Organometallic Compounds
1
1988
71
0.150
Why?
Camptothecin
1
2007
8
0.150
Why?
United States
4
1988
2511
0.150
Why?
Health Status Indicators
1
2008
97
0.150
Why?
Head and Neck Neoplasms
1
2008
78
0.140
Why?
Drug Therapy, Combination
4
1982
375
0.140
Why?
Drug Evaluation
8
1980
98
0.140
Why?
Treatment Failure
1
2007
125
0.140
Why?
Infusions, Intravenous
4
1989
139
0.140
Why?
Carcinoma, Squamous Cell
1
2008
230
0.130
Why?
Neoplasms, Second Primary
1
2008
124
0.130
Why?
Patient Selection
1
2007
197
0.130
Why?
Placebos
2
2000
177
0.120
Why?
Vinblastine
2
1986
27
0.120
Why?
Procarbazine
1
2004
12
0.120
Why?
Disease Progression
2
2000
496
0.110
Why?
Severity of Illness Index
2
2004
878
0.110
Why?
Antimetabolites, Antineoplastic
2
1998
38
0.110
Why?
Thoracic Neoplasms
1
2003
17
0.110
Why?
Medical Oncology
2
1992
40
0.110
Why?
Dysgerminoma
1
1982
8
0.110
Why?
Mediastinal Neoplasms
1
1982
21
0.100
Why?
Prognosis
4
1985
1030
0.100
Why?
Recombinant Proteins
2
1998
706
0.100
Why?
Lymphatic Metastasis
3
1994
137
0.100
Why?
Megestrol
1
2001
3
0.090
Why?
Oncologic Nursing
2
1992
8
0.090
Why?
Professional Staff Committees
1
2001
8
0.090
Why?
Radiation Oncology
1
2001
17
0.090
Why?
Hyperaldosteronism
1
1980
5
0.090
Why?
Patient Dropouts
1
2000
25
0.090
Why?
Thioguanine
1
1980
15
0.090
Why?
Quality-Adjusted Life Years
1
2000
50
0.090
Why?
Immunotherapy, Active
1
1999
6
0.080
Why?
Methotrexate
4
1982
73
0.080
Why?
Age Factors
2
1990
1060
0.080
Why?
Cancer Vaccines
1
1999
31
0.080
Why?
Mitomycins
3
1986
17
0.080
Why?
Interleukin-1
1
1999
204
0.080
Why?
Tomography, X-Ray Computed
3
1982
729
0.070
Why?
Prospective Studies
2
1993
1606
0.060
Why?
Dose-Response Relationship, Radiation
2
2003
205
0.060
Why?
Stomach Neoplasms
1
1995
34
0.060
Why?
Menopause, Premature
1
1994
2
0.060
Why?
Menstruation
1
1994
16
0.060
Why?
Premenopause
1
1994
12
0.060
Why?
Ovariectomy
1
1994
44
0.060
Why?
Randomized Controlled Trials as Topic
2
1992
400
0.060
Why?
Ovary
1
1994
89
0.060
Why?
Multicenter Studies as Topic
1
1994
126
0.060
Why?
Drug Utilization
1
1994
44
0.060
Why?
Fluoxymesterone
3
1997
4
0.060
Why?
Goserelin
1
1993
5
0.060
Why?
Occult Blood
1
1993
8
0.050
Why?
Prostatic Neoplasms
2
1989
548
0.050
Why?
Health Services Needs and Demand
1
1994
93
0.050
Why?
Analgesics, Opioid
1
1993
96
0.050
Why?
Psychology, Clinical
1
1992
5
0.050
Why?
Recurrence
2
1997
656
0.050
Why?
Regression Analysis
1
1993
489
0.050
Why?
Drug Therapy
1
1992
45
0.050
Why?
Education, Medical
1
1993
134
0.050
Why?
Colorectal Neoplasms
1
1993
138
0.050
Why?
Mitosis
2
2000
99
0.050
Why?
Quality of Life
2
1998
486
0.050
Why?
Drugs, Investigational
1
1990
8
0.050
Why?
Indazoles
1
1990
6
0.050
Why?
Behavior Therapy
1
1992
95
0.050
Why?
Cell Cycle
2
2001
247
0.050
Why?
Tumor Stem Cell Assay
1
2010
22
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2010
42
0.040
Why?
Dose Fractionation
1
2010
57
0.040
Why?
Retrospective Studies
2
1985
2167
0.040
Why?
Health Knowledge, Attitudes, Practice
1
1993
247
0.040
Why?
Translational Medical Research
1
2010
36
0.040
Why?
Eating
1
2010
80
0.040
Why?
Bias (Epidemiology)
1
1990
41
0.040
Why?
Aminoglutethimide
1
1989
6
0.040
Why?
Tumor Cells, Cultured
2
2001
871
0.040
Why?
Flavonoids
1
2010
64
0.040
Why?
Sensitivity and Specificity
2
1993
866
0.040
Why?
Psychometrics
1
2010
212
0.040
Why?
Hydrocortisone
1
1989
131
0.040
Why?
Abdominal Neoplasms
1
2008
14
0.040
Why?
Mucositis
1
2008
13
0.040
Why?
Carcinoid Tumor
1
2008
26
0.040
Why?
Glutamates
1
2008
34
0.040
Why?
Adenoma
1
2008
57
0.040
Why?
Pituitary Neoplasms
1
2008
64
0.040
Why?
Self-Assessment
1
2008
51
0.040
Why?
Deoxycytidine
1
2008
26
0.040
Why?
Cell Line, Tumor
1
2010
543
0.040
Why?
Guanine
1
2008
49
0.040
Why?
Carcinoma
1
1989
188
0.040
Why?
Clinical Trials as Topic
2
1986
664
0.040
Why?
Oxazoles
1
1986
8
0.030
Why?
Isoxazoles
1
1986
16
0.030
Why?
9,10-Dimethyl-1,2-benzanthracene
1
1986
36
0.030
Why?
Chronic Disease
1
2008
496
0.030
Why?
Antibiotics, Antineoplastic
1
1986
51
0.030
Why?
Cytosine
1
1986
33
0.030
Why?
Physicians
1
1988
143
0.030
Why?
Risk Factors
2
1993
2172
0.030
Why?
Anthracenes
1
1985
5
0.030
Why?
Leukopenia
1
1985
24
0.030
Why?
New York
1
1990
1191
0.030
Why?
Anthraquinones
1
1984
7
0.030
Why?
Hematologic Diseases
2
1986
40
0.030
Why?
Reproducibility of Results
1
2008
859
0.030
Why?
Dose-Response Relationship, Drug
1
2008
1085
0.030
Why?
Glucocorticoids
1
1986
159
0.030
Why?
Mammary Neoplasms, Experimental
1
1986
230
0.030
Why?
Lung Diseases
1
1986
224
0.030
Why?
Risk Assessment
1
2008
808
0.030
Why?
Young Adult
1
2008
1013
0.030
Why?
Maximum Tolerated Dose
1
2003
16
0.030
Why?
G2 Phase
1
2003
30
0.030
Why?
Leucovorin
1
1982
12
0.030
Why?
Iodipamide
1
1982
9
0.030
Why?
Diatrizoate
1
1982
18
0.030
Why?
Diatrizoate Meglumine
1
1982
17
0.030
Why?
Prednisone
2
1986
178
0.030
Why?
Cytarabine
1
1982
82
0.030
Why?
Burkitt Lymphoma
1
1982
47
0.020
Why?
Mesothelioma
1
2001
30
0.020
Why?
Radiotherapy Dosage
1
2001
185
0.020
Why?
Organizational Objectives
1
2001
21
0.020
Why?
Spironolactone
1
1980
12
0.020
Why?
Aldosterone
1
1980
20
0.020
Why?
Ascites
1
1980
21
0.020
Why?
Diarrhea
1
2000
61
0.020
Why?
Axilla
1
2000
21
0.020
Why?
Interprofessional Relations
1
2001
69
0.020
Why?
Serum Albumin
1
1980
95
0.020
Why?
Alkaline Phosphatase
1
1980
135
0.020
Why?
Likelihood Functions
1
2000
52
0.020
Why?
Forecasting
1
2001
172
0.020
Why?
Blood Cell Count
1
1980
44
0.020
Why?
Hodgkin Disease
1
1982
152
0.020
Why?
Bilirubin
1
1980
68
0.020
Why?
Edema
1
1980
108
0.020
Why?
Cause of Death
1
2000
155
0.020
Why?
Europe
1
1999
74
0.020
Why?
Hepatitis B Antibodies
1
1999
11
0.020
Why?
Lipid A
1
1999
9
0.020
Why?
Mycobacterium
1
1999
7
0.020
Why?
Skin Tests
1
1999
35
0.020
Why?
Adolescent
1
2008
4513
0.020
Why?
Receptors, Estrogen
2
1984
180
0.020
Why?
Mitolactol
1
1998
6
0.020
Why?
Adjuvants, Immunologic
1
1999
118
0.020
Why?
Flow Cytometry
1
2000
597
0.020
Why?
Apoptosis
1
2003
782
0.020
Why?
Mastectomy
1
1997
41
0.020
Why?
Cohort Studies
1
2000
912
0.020
Why?
Bone Neoplasms
1
1998
180
0.020
Why?
Follicle Stimulating Hormone
1
1993
49
0.010
Why?
Gonadal Steroid Hormones
1
1993
35
0.010
Why?
Reagent Kits, Diagnostic
1
1993
17
0.010
Why?
Attitude of Health Personnel
1
1994
267
0.010
Why?
Mass Screening
1
1993
223
0.010
Why?
Gastrointestinal Diseases
1
1986
38
0.010
Why?
Central Nervous System Diseases
1
1986
58
0.010
Why?
Respiratory Function Tests
1
1986
121
0.010
Why?
Interferons
1
1986
46
0.010
Why?
Organ Size
1
1986
189
0.010
Why?
Progesterone
1
1986
93
0.010
Why?
Rats, Inbred Strains
1
1986
636
0.010
Why?
Mitoxantrone
1
1984
20
0.010
Why?
Bone Marrow
1
1986
282
0.010
Why?
Rats
1
1986
4185
0.000
Why?
Animals
1
1986
15647
0.000
Why?

Visualizations


Pandya's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department